Abiomed, Inc.ABMDNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+9.6%
5Y CAGR+14.2%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+9.6%/yr
vs +26.5%/yr prior
5Y CAGR
+14.2%/yr
Recent deceleration
Acceleration
-16.8pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2022$423.49M+26.7%
2021$334.18M-2.2%
2020$341.60M+6.2%
2019$321.55M+22.4%
2018$262.73M+20.4%
2017$218.15M+32.8%
2016$164.26M+30.6%
2015$125.73M+17.2%
2014$107.25M+27.3%
2013$84.23M-